During the past decade, Atrium Medisch Centrum Brunssum conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Atrium Medisch Centrum Brunssum" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "Lymphoma Study Association" with 1 trials as a collaborator and "UNICANCER" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Atrium Medisch Centrum Brunssum" are "Diabetes Mellitus, Type 2" (1 trials) and "Lymphoma" (1 trials). Many other conditions were trialed in "Atrium Medisch Centrum Brunssum" in a lesser frequency.

Most popular intervention types in "Atrium Medisch Centrum Brunssum" are "Drug" (2 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "ABVD regimen" (1 trials), "BEACOPP regimen" (1 trials), "Exenatide (AC2993)" (1 trials), "Insulin glargine" (1 trials) and "bleomycin sulfate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Atrium Medisch Centrum Brunssum" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Atrium Medisch Centrum Brunssum". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Atrium Medisch Centrum Brunssum, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Atrium Medisch Centrum Brunssum, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".